Amgen

Amgen teams up with Adaptive to both treat and prevent COVID-19
Amgen teams up with Adaptive to both treat and prevent COVID-19
Fierce Biotech
Amgen
Adaptive Biotechnologies
R&D
COVID-19
Flag link:
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Fierce Biotech
Amgen
KRAS
AMG 510
COVID-19
clinical trials
cancer
Flag link:
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients
Fierce Pharma
ACC
Repatha
HIV
clinical trials
Amgen
Flag link:
Drug makers grounding salespeople as coronavirus impact on business spreads
Drug makers grounding salespeople as coronavirus impact on business spreads
Stat
Amarin
Amgen
Merck
drug reps
coronaviruses
COVID-19
Flag link:
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Amgen
Allergan
biosimilars
Roche
rituximab
Flag link:
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
biosimilars
Amgen
Allergan
Roche
Rituxan
Bristol-Myers Squibb
ozanimod
risdiplam
Biomarin
valrox
Flag link:
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Big Pharma grounds employees: GSK, Bristol, Roche, Sanofi and more limit travel due to coronavirus
Fierce Pharma
COVID-19
coronaviruses
Roche
GSK
Bristol-Myers Squibb
Sanofi
Boehringer Ingelheim
Amgen
Biogen
Mylan
Flag link:
Pfizer, Amgen, Lilly spent most to lobby Congress, study finds
Pfizer, Amgen, Lilly spent most to lobby Congress, study finds
BioPharma Dive
pharma industry
lobbying
Pfizer
Amgen
Eli Lilly
Flag link:
Trial of Amgen, Servier’s heart failure drug clears interim check
Trial of Amgen, Servier’s heart failure drug clears interim check
PM Live
Amgen
Servier
chronic heart failure
Omecamtiv Mecarbil
clinical trials
Flag link:
Amgen heart drug passes interim check, setting up year-end readout
Amgen heart drug passes interim check, setting up year-end readout
BioPharma Dive
Amgen
Omecamtiv Mecarbil
Cytokinetics
Flag link:
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Flag link:
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
Motley Fool
Amgen
earnings
M&A
Asia
Flag link:
Amgen, Pfizer biosimilar sales pressure top drugs
Amgen, Pfizer biosimilar sales pressure top drugs
BioPharma Dive
biosimilars
Amgen
Pfizer
Roche
Flag link:
Amgen Revenue Slipped 1% in the Fourth Quarter
Amgen Revenue Slipped 1% in the Fourth Quarter
Motley Fool
Amgen
earnings
Flag link:
Big pharma backed away from brain drugs. Is a return in sight?
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
Flag link:
Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Amgen wades deeper into Asia with full control of an Astellas Japanese JV
Fierce Pharma
Amgen
Astellas
Japan
BeiGene
China
Flag link:
Who are the 10 Most Innovative Biopharma Companies?
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Flag link:
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
With Rising Drug Prices a Concern, Some Companies Enact Their Own Control Plans
BioSpace
drug pricing
Roche
Eli Lilly
Amgen
Alnylam
Sanofi
Flag link:
Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads
Merck, Lilly and Amgen square off in appeals court over drug pricing in TV ads
Fierce Pharma
Merck
Eli Lilly
Amgen
HHS
drug pricing
television ads
Flag link:
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Flag link:

Pages